Johnson & Johnson COVID-19 Vaccine Candidate Interim Phase 1/2a Data Published in New England Journal of Medicine
January 13, 2021 -- Interim Phase 1/2a data were published today in the New England Journal of Medicine demonstrating that the Company’s single-dose investigational COVID-19 vaccine candidate (JNJ-78436735) – being developed by the Janssen Pharmaceutical Companies of Johnson & Johnson – provided an immune response that lasted for at least 71 days, the duration of time measured in this study in participants aged 18-55 years. A preview of part of these interim data was posted on medRxiv in September 2020.The Phase 1/2a interim analysis showed that the Company’s COVID-19 vaccine candidate induced a...
Source: Johnson and Johnson - January 13, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

WHO and Partners to Stockpile Ebola Vaccine
TUESDAY, Jan. 12, 2021 -- Ebola vaccines are being stockpiled by the World Health Organization and other groups to combat future outbreaks of the deadly disease. An emergency reserve of about 500,000 doses of a Merck vaccine will be established,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 12, 2021 Category: Pharmaceuticals Source Type: news

Africa: UN Agencies, Partners Establish Global Ebola Vaccine Stockpile
[UN News] In a major milestone in the fight against deadly diseases, United Nations agencies and humanitarian partners announced on Tuesday, the establishment of a global Ebola vaccine stockpile, to help control future epidemics by ensuring timely access to vaccines for populations at risk, during outbreaks. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 12, 2021 Category: African Health Source Type: news

Ebola vaccines stockpiled against future outbreaks
The World Health Organization and partners say they are creating a global stockpile of Ebola vaccines to help stamp out future outbreaks (Source: ABC News: Health)
Source: ABC News: Health - January 12, 2021 Category: Consumer Health News Tags: Health Source Type: news

UN agencies, partners establish global Ebola vaccine stockpile
In a major milestone in the fight against deadly diseases, United Nations agencies and humanitarian partners announced on Tuesday, the establishment of a global Ebola vaccine stockpile, to help control future epidemics by ensuring timely access to vaccines for populations at risk, during outbreaks.  (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - January 12, 2021 Category: International Medicine & Public Health Source Type: news

UN agencies and partners establish global Ebola vaccine stockpile
In a major milestone in the fight against deadly diseases, United Nations agencies and humanitarian partners announced on Tuesday, the establishment of a global Ebola vaccine stockpile, to help control future epidemics by ensuring timely access to vaccines for populations at risk, during outbreaks.  (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - January 12, 2021 Category: International Medicine & Public Health Source Type: news

The Oxford-AstraZeneca Vaccine Approval May Be the Most Globally Important Yet
The COVID-19 vaccine developed by the University of Oxford and AstraZeneca wasn’t the first to be OK’d by regulators in the U.K.—health officials authorized the Pfizer-BioNTech jab nearly four weeks earlier. And it’s not the most effective—Stage 3 clinical trials suggest it prevents COVID-19 symptoms about 70% of the time vs. about 95% for the Pfizer vaccine and a similar one from Moderna (which is authorized in the U.S., but not the U.K.). But the greenlight from the British Medicines and Healthcare Products Regulatory Agency on Wednesday could be a big step toward bringing the COVID-19 pande...
Source: TIME: Health - December 30, 2020 Category: Consumer Health News Authors: Michael Zennie Tags: Uncategorized COVID-19 Explainer overnight Source Type: news

Why Africa ’s COVID-19 Outbreak Hasn’t Been as Bad as Everyone Feared
When COVID-19 initially blazed through Asia, Europe and then the United States, global public health experts worried that it could be catastrophic for Africa, with its crowded cities, poorly funded health sector and lack of testing facilities. The U.N. Economic Commission for Africa in April predicted up to 300,000 deaths this year if the virus couldn’t be contained on the continent. Yet it was the U.S, with its superior health system, that hit that grim milestone first, and so far, Africa has been largely spared the worst of the devastation experienced by the rest of the world. As of Dec. 29, the Africa Centres for ...
Source: TIME: Health - December 30, 2020 Category: Consumer Health News Authors: Aryn Baker Tags: Uncategorized COVID-19 Londontime Source Type: news

Uganda: Is Uganda Ready to Acquire the Covid-19 Vaccine?
[Monitor] The world's population, years over, has been affected by a number of viral diseases such a Ebola and Influenza which, in some cases, have caused millions of deaths. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 21, 2020 Category: African Health Source Type: news

Top Global Health Moments of 2020
By The Editorial Team, IntraHealth International Community Health Nurse Olivia Yeboah thoroughly washes her hands at the Akropong Clinic in Ghana. Photo by Emmanuel Attramah, PMI Impact Malaria/US President's Malaria Initiative.December 17, 2020If we wanted to, we could list a COVID-19 moment for every month of 2020.  We all know that the onset of the coronavirus pandemic—first in China and then worldwide—overwhelmed news coverage this year. And with good reason. It’s the first large-scale global pandemic in 100 years. At the time this article was publ...
Source: IntraHealth International - December 17, 2020 Category: International Medicine & Public Health Authors: kseaton Tags: HIV & AIDS COVID-19 Nutrition Policy Advocacy Health Workforce Systems Nursing Midwifery 2020 Health Workers Source Type: news

We All Deserve Protection From Covid-19
Credit: United NationsBy Adaora OkoliNEW ORLEANS, US, Dec 11 2020 (IPS) When I contracted Ebola virus disease in August 2014 while working as a medical doctor in a well-known private hospital in Lagos, Nigeria, I was denied access to a potential cure. For 15 days, I battled for my life in a debilitated isolation ward, not knowing if I would survive. But American aid workers who contracted Ebola were administered Zmapp, a monoclonal antibody treatment, which reduces the relative risk of death from Ebola by 40% as well as shorten the duration of stay in the Ebola treatment units. They survived. We were told that Zmapp was e...
Source: IPS Inter Press Service - Health - December 11, 2020 Category: International Medicine & Public Health Authors: Adaora Okoli Tags: Headlines Health TerraViva United Nations Source Type: news

Even the Pandemic Hasn ’t Made Public-Health Icon Paul Farmer Lose Hope
“Am I allowed to be a normal human and say, ‘How are you?'” asks Dr. Paul Farmer as soon as our Zoom call connects. It’s an apt introduction for a man who became a living legend in the global health world mostly by being a normal human who does extraordinary things–starting with co-founding the Boston-based nonprofit organization Partners in Health (PIH) in 1987, before graduating from Harvard Medical School. Since then, PIH and its global staff of 18,000 have helped strengthen health systems in the “clinical deserts” of Haiti, Rwanda, Peru, Russia and numerous other countries. PIH...
Source: TIME: Health - December 3, 2020 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 Magazine Public Health Second click Source Type: news

Cutting UK overseas aid could harm the fight against future pandemics | Matthew Baylis and Fiona Tomley
In our age of emerging pathogens, funding for global research into zoonotic diseases such as Covid-19, Ebola and Sars is vitalCoronavirus – latest updatesSee all our coronavirus coverageThis year, we ’ve seen how a previously unknown animal virus can spill over into the human population in one country, pass rapidly between people, and spread across the world in days. With nearly1.5m reported deaths from Covid-19, the virus is a startling indication of how the health of the world ’s human population is inseparable from animals and the environment that we share with them.Treating health in a way that recogn...
Source: Guardian Unlimited Science - December 2, 2020 Category: Science Authors: Matthew Baylis and Fiona Tomley Tags: Vaccines and immunisation Coronavirus Infectious diseases Microbiology Science Health World news Society Medical research Ebola Sars Aid UK news Source Type: news

Janssen's Two-Dose Ebola Vaccine Appears Safe, Immunogenic in HIV-Infected Patients Janssen's Two-Dose Ebola Vaccine Appears Safe, Immunogenic in HIV-Infected Patients
Janssen's two-dose Ebola vaccine appears to be safe for HIV-infected patients and provokes an immune response, although one that initially is not as strong as in HIV-negative patients, according to new research.Reuters Health Information (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - December 2, 2020 Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news

Japan Should Lead Charge for Equitable Access to COVID-19 Vaccines
Credit: United NationsBy Cecilia RussellJOHANNESBURG, South Africa, Nov 20 2020 (IPS) Japan should step up and play a role as a global facilitator for equitable access to COVID-19 vaccines, Dr Daisaku Higashi said at a recent Japan Parliamentarians Federation for Population (JPFP) study meeting. The country should use the credibility developed in the post-Second World War era as a country with expertise in peacebuilding to ensure that developing countries are included in the vaccines’ rollout. Higashi, a renowned commentator from Sophia University, warned that only an international effort could solve the problems ca...
Source: IPS Inter Press Service - Health - November 20, 2020 Category: International Medicine & Public Health Authors: Cecilia Russell Tags: Aid Asia-Pacific Development & Aid Economy & Trade Featured Global Headlines Health Humanitarian Emergencies TerraViva United Nations Asian Population and Development Association (APDA) Source Type: news

Third Covid-19 candidate vaccine developed by Janssen Pharmaceutical Companies will be tested in clinical trials involving patients in the UK
Phase 3 placebo controlled RCT will involve 30,000 patients and assess a two dose regimen of the vaccine 57 days apart, using the same human adenovirus that provided the vector for Janssen's Ebola virus vaccine. A trial of a single dose by Janssen is already underway in the US. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - November 18, 2020 Category: Consumer Health News Source Type: news

Covid: 6,000 UK volunteers to be injected with vaccine in phase 3 trial
Third vaccine to undergo large-scale clinical testing in Britain has been modelled on Ebola jabCoronavirus – latest updatesSee all our coronavirus coverageSix thousand British volunteers are to be injected with an experimental Covid vaccine modelled on an Ebola jab.It is the third Covid vaccine to enter large-scale clinical trials in the UK. Pursuing multiple candidates is essential to guarantee UK supply and ensure that most effective vaccine is identified, researchers stressed.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - November 16, 2020 Category: Science Authors: Linda Geddes Tags: Coronavirus Vaccines and immunisation Health Infectious diseases Medical research UK news Alok Sharma Science Source Type: news

Johnson & Johnson Initiates Second Global Phase 3 Clinical Trial of its Janssen COVID-19 Vaccine Candidate
November 15, 2020 -- The Phase 3 ENSEMBLE study of the single-dose regimen of JNJ-78436735, the investigational vaccine candidate for the prevention of COVID-19 being developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, continues to enroll and vaccinate study participants. ENSEMBLE is proceeding to enroll up to 60,000 participants worldwide.In addition to the single-dose regimen ENSEMBLE study, Janssen has now initiated the two-dose regimen ENSEMBLE 2 trial. ENSEMBLE 2 is a complementary, planned, pivotal, large-scale, multi-country Phase 3 trial that will study the safety and efficacy of a two-dose ...
Source: Johnson and Johnson - November 16, 2020 Category: Pharmaceuticals Tags: Our Company Source Type: news

Why You May Not Be Able to Get Pfizer ’s Frontrunner COVID-19 Vaccine
The freezer in your kitchen likely gets down to temperatures around -20° C (-4° F). “That keeps your ice cream cold, but it doesn’t turn your ice cream into an impenetrable block of ice,” says Paula Cannon, an associate professor of molecular microbiology and immunology at the University of Southern California’s Keck School of Medicine. Pfizer’s promising COVID-19 vaccine, by contrast, must be stored at about -70° C (-94° F)—a temperature cold enough to harden ice cream into a spoon-breaking block of ice, and that only specialized freezers can produce. Those cold storage ...
Source: TIME: Health - November 13, 2020 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 Source Type: news

COMMENTARY: The Sinatra Doctrine Confronts a Global Consensus
A photo-collage. Credit: Peter Costantini.By Peter CostantiniSEATTLE, Oct 23 2020 (IPS) By late September, the COVID-19 pandemic in the United States had claimed 200,000 lives. That’s equivalent to a slightly higher toll than the 418,500 United States deaths in World War II, adjusted for relative population and duration. [See note below.] With four percent of the world’s population, the U.S. has suffered 20 percent of global COVID-19 deaths. Tragically, most of these deaths need never have happened. They were caused primarily by the public-health equivalent of friendly fire: massive malpractice and deception by...
Source: IPS Inter Press Service - Health - October 23, 2020 Category: International Medicine & Public Health Authors: Peter Costantini Tags: Global Geopolitics Global Governance Headlines Health TerraViva United Nations Source Type: news

What Developing Countries Can Teach Us About How To Respond To a Pandemic
This article is republished from The Conversation under a Creative Commons license. Read the original article. The post What Developing Countries Can Teach Us About How To Respond To a Pandemic appeared first on Inter Press Service. (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - October 16, 2020 Category: International Medicine & Public Health Authors: External Source Tags: Global Headlines Health TerraViva United Nations Source Type: news

Heidi Larson Knows How to Build Trust in Vaccines
For the founder of the Vaccine Confidence Project, squashing viral rumors means building trust — and avoiding the term “anti-vaxxer.” (Source: NYT Health)
Source: NYT Health - October 13, 2020 Category: Consumer Health News Authors: Jenny Anderson Tags: your-feed-science Coronavirus Risks and Safety Concerns Vaccination and Immunization Coronavirus (2019-nCoV) Rumors and Misinformation Polls and Public Opinion Social Media Computers and the Internet Mumps Measles Epidemics Ebola Vir Source Type: news

Johnson & Johnson Announces European Commission Approval of Agreement to Supply 200 Million Doses of Janssen ’s COVID-19 Vaccine Candidate
New Brunswick, N.J., October 8, 2020 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced the European Commission (EC), acting on behalf of the European Union (EU) Member States, has approved an Advance Purchase Agreement in which the Janssen Pharmaceutical Companies will supply 200 million doses of its COVID-19 vaccine candidate to EU Member States following approval or authorization from regulators. The EU Member States also have the option to secure up to 200 million additional doses.“The COVID-19 pandemic continues to threaten communities worldwide and we have a responsibility to ensure access ...
Source: Johnson and Johnson - October 8, 2020 Category: Pharmaceuticals Tags: Our Company Source Type: news

Stop a Pandemic Without Water? Health Workers across the World Need WASH
This article was originally published by the Frontline Health Workers coalition on September 30, 2020.Read it here. (Source: IntraHealth International)
Source: IntraHealth International - September 30, 2020 Category: International Medicine & Public Health Authors: kseaton Tags: COVID-19 Global health security Source Type: news

J & J ’s COVID-19 Vaccine Will Enter Phase 3 Testing, the Fourth To Reach That Stage
Johnson & Johnson announced today (Sept. 23) that it is launching a large-scale Phase 3 test of its COVID-19 vaccine candidate, which was developed based on science supported by the National Institutes of Health. The vaccine, being tested through the company’s Janssen Pharmaceuticals arm, will be the fourth to enter late stage studies, following candidates from Moderna, Pfizer-BioNTech and AstraZeneca. Unlike those vaccine candidates, which all require two shots, J&J’s vaccine involves a single injection. That means it could require half the number of doses to immunize the same number of people. J&J...
Source: TIME: Health - September 23, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Johnson & Johnson ’ s Coronavirus Vaccine Enters Phase 3 Trial With Beth Israel
cbsoptanon.onScriptsReady(function(cmp){cmp.ot.targetingAllowed(function(a){if(a) AnvatoPlayer("p1").init({"mcp":"cbs","width":"100%","height":"100%","video":"4730668","autoplay":false,"titleVisible":false,"accessKey":"EZqvRyKE7qmqDflDPXIw6U7kKZEA0Vx7","accessControl":{"preview":false},"pInstance":"p1","plugins":{"heartbeat":{"account":"cbslocal-global-unified","publisherId":"cbslocal","jobId...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - September 23, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Covid-19 Boston, MA Health Healthcare Status Beth Israel Deacones Medical Center Coronavirus Johnson & Johnson Source Type: news

Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen ’s COVID-19 Vaccine Candidate
NEW BRUNSWICK, N.J., September 23, 2020 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its Janssen Pharmaceutical Companies. The initiation of the ENSEMBLE trial follows positive interim results from the Company’s Phase 1/2a clinical study, which demonstrated that the safety profile and immunogenicity after a single vaccination were supportive of further development. These results have been submitted to medRxiv and are due to be published online i...
Source: Johnson and Johnson - September 23, 2020 Category: Pharmaceuticals Tags: Our Company Source Type: news

Who Should Receive the New Ebola Vaccine? Who Should Receive the New Ebola Vaccine?
While the world waits for an effective COVID vaccine, let's not overlook the vaccine now available for an even deadlier disease.Medscape Internal Medicine (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - September 22, 2020 Category: Infectious Diseases Tags: Infectious Diseases Commentary Source Type: news

The Great Vaccine Race: Inside the Unprecedented Scramble to Immunize the World Against COVID-19
The cleverest of enemies thrive on surprise attacks. Viruses—and coronaviruses in particular—know this well. Remaining hidden in animal hosts for decades, they mutate steadily, sometimes serendipitously morphing into more effective and efficient infectious agents. When a strain with just the right combination of genetic codes that spell trouble for people makes the leap from animal to human, the ambush begins. Such was the case with SARS-CoV-2, the coronavirus behind COVID-19, and the attack was mostly silent and insidious at first. Many people infected with SARS-CoV-2 remained oblivious as they served as the v...
Source: TIME: Health - September 10, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Magazine Source Type: news

Biopharma Leaders Unite To Stand With Science
NEW YORK, September 8, 2020 — The CEOs of AstraZeneca (LSE/STO/NYSE: AZN), BioNTech (NASDAQ: BNTX), GlaxoSmithKline plc (LSE/NYSE: GSK), Johnson & Johnson (NYSE: JNJ), Merck (NYSE: MRK), known as MSD outside the United States and Canada, Moderna, Inc. (Nasdaq: MRNA), Novavax, Inc. (Nasdaq: NVAX), Pfizer Inc. (NYSE: PFE), and Sanofi (NASDAQ: SNY), today announced a historic pledge, outlining a united commitment to uphold the integrity of the scientific process as they work towards potential global regulatory filings and approvals of the first COVID-19 vaccines. All nine CEOs signed the following pledge: We, the un...
Source: Johnson and Johnson - September 8, 2020 Category: Pharmaceuticals Tags: Our Company Source Type: news

Navigating Safely Through The Pandemic
By Stephen LeahySep 2 2020 (IPS-Partners) Having reported on SARS, Ebola, Bird Flu (H5N1) outbreaks, as well as writing about efforts to combat HIV, I was horrified by what was going on in Wuhan, China last Jan mainly because of how fast this new SARS-CoV-2 virus spread. By early Feb it seemed likely there’d be a global pandemic and by the end of Feb I started to freak out as the pandemic took hold. I’ve never been to Wuhan or China nor seen anyone who had; and I hadn’t travelled any where recently. It was nearly impossible for me to have encountered the virus but that didn’t keep me from getting si...
Source: IPS Inter Press Service - Health - September 2, 2020 Category: International Medicine & Public Health Authors: Stephen Leahy Tags: Health Humanitarian Emergencies Source Type: news

Exclusive: The Scientist Who Sequenced the First COVID-19 Genome Speaks Out About the Controversies Surrounding His Work
Over the past few years, Professor Zhang Yongzhen has made it his business to sequence thousands of previously unknown viruses. But he knew straight away that this one was particularly nasty. It was about 1:30 p.m. on Jan. 3 that a metal box arrived at the drab, beige buildings that house the Shanghai Public Health Clinical Center. Inside was a test tube packed in dry ice that contained swabs from a patient suffering from a peculiar pneumonia sweeping China’s central city of Wuhan. But little did Zhang know that that box would also unleash a vicious squall of blame and geopolitical acrimony worthy of Pandora herself....
Source: TIME: Health - August 25, 2020 Category: Consumer Health News Authors: Charlie Campbell / Shanghai Tags: Uncategorized COVID-19 overnight Source Type: news

Exclusive: The Chinese Scientist Who Sequenced the First COVID-19 Genome Speaks Out About the Controversies Surrounding His Work
Over the past few years, Professor Zhang Yongzhen has made it his business to sequence thousands of previously unknown viruses. But he knew straight away that this one was particularly nasty. It was about 1:30 p.m. on Jan. 3 that a metal box arrived at the drab, beige buildings that house the Shanghai Public Health Clinical Center. Inside was a test tube packed in dry ice that contained swabs from a patient suffering from a peculiar pneumonia sweeping China’s central city of Wuhan. But little did Zhang know that that box would also unleash a vicious squall of blame and geopolitical acrimony worthy of Pandora herself....
Source: TIME: Science - August 25, 2020 Category: Science Authors: Charlie Campbell / Shanghai Tags: Uncategorized COVID-19 overnight Source Type: news

Exclusive: The Chinese Scientist Who Sequenced the First COVID-19 Genome Speaks Out About the Controversies Surrounding His Work
Over the past few years, Professor Zhang Yongzhen has made it his business to sequence thousands of previously unknown viruses. But he knew straight away that this one was particularly nasty. It was about 1:30 p.m. on Jan. 3 that a metal box arrived at the drab, beige buildings that house the Shanghai Public Health Clinical Center. Inside was a test tube packed in dry ice that contained swabs from a patient suffering from a peculiar pneumonia sweeping China’s central city of Wuhan. But little did Zhang know that that box would also unleash a vicious squall of blame and geopolitical acrimony worthy of Pandora herself....
Source: TIME: Health - August 25, 2020 Category: Consumer Health News Authors: Charlie Campbell / Shanghai Tags: Uncategorized COVID-19 overnight Source Type: news

How Convalescent Plasma Could Help Fight COVID-19
The last time most of us gave any thought to antibodies was probably in high school biology, but we’re getting a crash refresher course thanks to COVID-19. They are, after all, the key to our best defenses against SARS-CoV-2, the virus that’s caused the global pandemic. People who have been infected likely rely on antibodies to recover, and antibodies are what vaccines are designed to produce. Or at least that’s what infectious-disease and public-health experts assume for now. Because SARS-CoV-2 is such a new virus, even the world’s best authorities aren’t yet sure what it will take to build p...
Source: TIME: Health - August 24, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Leading in Time of COVID: A True Test of Leadership
By Folake OlayinkaAug 15 2020 (IPS) In 1918, the Spanish Flu, a deadly influenza caused by the H1N1 virus, decimated the world. Over the course of four successive waves, it infected 500 million people, about a third of the world’s population at the time, resulting in 50 million deaths. More recently between 2014 and mid-2016 , the Ebola virus epidemic was the most widespread outbreak of Ebola virus disease in history—causing devastating  loss of life and socioeconomic disruption in the West Africa region, mainly in Guinea, Liberia and Sierra Leone. These outbreaks, as well as SARS and MERS, each have ...
Source: IPS Inter Press Service - Health - August 15, 2020 Category: International Medicine & Public Health Authors: Folake Olayinka Tags: Democracy Headlines Health Source Type: news

Johnson & Johnson Announces Agreement with U.S. Government for 100 Million Doses of Investigational COVID-19 Vaccine
New Brunswick, N.J., August 05, 2020 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced its Janssen Pharmaceutical Companies have entered into an agreement with the U.S. government for the large scale domestic manufacturing and delivery in the U.S. of 100 million doses of Janssen’s SARS-CoV-2 investigational vaccine, Ad26.COV2.S, for use in the United States following approval or Emergency Use Authorization by the U.S. Food and Drug Administration (FDA). The Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services’ Office of th...
Source: Johnson and Johnson - August 5, 2020 Category: Pharmaceuticals Tags: Our Company Source Type: news

Religion & the Pandemic: A Call Beyond the Here & Now
Religions for Peace Interreligious Council of Albania distributing Covid relief supplies from the Multi-religious Humanitarian Fund. Credit: Erzen CarjaBy Prof. Azza KaramNEW YORK, Aug 4 2020 (IPS) — I have never been interested in religion or spirituality before, but I found myself tuning in to all sorts of on-line religion and spirituality related forums “in search of something.” These are the words of a 30-something single young, middle class man (born into a Protestant-Catholic family background) in a European country. The latter is known more for turning several churches into museums or shopping ce...
Source: IPS Inter Press Service - Health - August 4, 2020 Category: International Medicine & Public Health Authors: Azza Karam Tags: Civil Society Featured Global Headlines Health Human Rights Humanitarian Emergencies Inequity Religion TerraViva United Nations Source Type: news

Dr. Anthony Fauci Expresses ‘Cautious’ Optimism That COVID-19 Vaccine Will Be Available to Americans in 2021
(WASHINGTON) — Once a coronavirus vaccine is approved as safe and effective, Americans should have widespread access within a reasonable time, Dr. Anthony Fauci assured lawmakers Friday. Appearing before a House panel investigating the nation’s response to the pandemic, Fauci expressed “cautious” optimism that a vaccine would be available, particularly by next year. “I believe, ultimately, over a period of time in 2021, that Americans will be able to get it,” Fauci said, referring to the vaccine. There will be a priority list for who gets early vaccinations. “I don’t think we...
Source: TIME: Health - July 31, 2020 Category: Consumer Health News Tags: Uncategorized Congress COVID-19 News Desk wire Source Type: news

Inside the Global Quest to Trace the Origins of COVID-19 —and Predict Where It Will Go Next
It wasn’t greed, or curiosity, that made Li Rusheng grab his shotgun and enter Shitou Cave. It was about survival. During Mao-era collectivization of the early 1970s, food was so scarce in the emerald valleys of southwestern China’s Yunnan province that farmers like Li could expect to eat meat only once a year–if they were lucky. So, craving protein, Li and his friends would sneak into the cave to hunt the creatures they could hear squeaking and fluttering inside: bats. Li would creep into the gloom and fire blindly at the vaulted ceiling, picking up any quarry that fell to the ground, while his companion...
Source: TIME: Health - July 23, 2020 Category: Consumer Health News Authors: Charlie Campbell/ Yuxi, Yunnan and Alice Park Tags: Uncategorized COVID-19 feature Magazine Source Type: news

Report: Members of Russia ’s ‘Business and Political Elite’ Have Been Receiving Experimental COVID-19 Vaccine
(Bloomberg) — Scores of Russia’s business and political elite have been given early access to an experimental vaccine against COVID-19, according to people familiar with the effort, as the country races to be among the first to develop an inoculation. Top executives at companies including aluminum giant United Co. Rusal, as well as billionaire tycoons and government officials began getting shots developed by the state-run Gamaleya Institute in Moscow as early as April, the people said. They declined to be identified as the information isn’t public. The Gamaleya vaccine, financed by the state-run Russian D...
Source: TIME: Health - July 20, 2020 Category: Consumer Health News Authors: Stepan Kravchenko, Yuliya Fedorinova and Ilya Arkhipov / Bloomberg Tags: Uncategorized COVID-19 News Desk russia wire Source Type: news

Johnson & Johnson Reports 2020 Second-Quarter Results
New Brunswick, N.J. (July 16, 2020) – Johnson & Johnson (NYSE: JNJ) today announced results for second-quarter 2020. “Our second quarter results reflect the impact of COVID-19 and the enduring strength of our Pharmaceutical business, where we saw continued growth even in this environment,” said Alex Gorsky, Chairman and Chief Executive Officer. “Thanks to the tireless work of our colleagues around the world and our broad range of capabilities, we continue to successfully navigate the external landscape, and we remain focused on advancing the development of a vaccine to help address this pandemic...
Source: Johnson and Johnson - July 16, 2020 Category: Pharmaceuticals Source Type: news

UN Chief Warns of Deadly Germs as Potential Bioterrorist Weapons
Credit: United NationsBy Thalif DeenUNITED NATIONS, Jul 8 2020 (IPS) The coronavirus—which has claimed the lives of over 538,000 people and infected more than 11.6 million worldwide—has destabilized virtually every facet of human life ever since its outbreak in late December. Providing a grim economic scenario of the devastation caused by the pandemic– including rising poverty, hunger and unemployment– UN Secretary-General Antonio Guterres warned last week of the possibility of an even worse disaster: the risks of bioterrorist attacks deploying deadly germs. He said it has already shown some of the...
Source: IPS Inter Press Service - Health - July 8, 2020 Category: International Medicine & Public Health Authors: Thalif Deen Tags: Armed Conflicts Featured Global Global Geopolitics Global Governance Headlines Health IPS UN: Inside the Glasshouse Peace TerraViva United Nations Source Type: news

'I'm cautiously optimistic': Imperial's Robin Shattock on his coronavirus vaccine
Team is using new approach that could be cheap and scalable and become the norm within five yearsProf Robin Shattock would have liked slightly longer to develop the revolutionary approach to vaccines that he is pretty sure will not only save lives in the Covid-19 pandemic but become the norm for vaccine development within five years.His team at Imperial College were working on Ebola and Lassa fever vaccines using new technology but had not got as far as human trials when a novel coronavirus started to kill thousands of people in Wuhan, China.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - July 3, 2020 Category: Science Authors: Sarah Boseley Health editor Tags: Vaccines and immunisation Coronavirus outbreak Medical research Health Science Society Source Type: news

Johnson & Johnson Announces European Commission Approval for Janssen ’s Preventive Ebola Vaccine
Discussions with the U.S. Food and Drug Administration (FDA) have taken place to define the required data set for filing US licensure. About Janssen’s Ebola Vaccine Regimen The Janssen preventive Ebola vaccine regimen, Ad26.ZEBOV and MVA-BN-Filo, utilizes a non-replicating viral vector strategy in which viruses – in this case adenovirus serotype 26 (Ad26) and Modified Vaccinia Virus Ankara (MVA) – are genetically modified so that they cannot replicate in human cells. In addition, these vectors carry the genetic code of several Ebola virus proteins in order to trigger an immune response.Janssen’s vac...
Source: Johnson and Johnson - July 1, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

How Deforestation Helps Deadly Viruses Jump from Animals to Humans
This article is republished from The Conversation under a Creative Commons license. Read the original article. The post How Deforestation Helps Deadly Viruses Jump from Animals to Humans appeared first on Inter Press Service. (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - June 26, 2020 Category: International Medicine & Public Health Authors: External Source Tags: Environment Global Headlines Health TerraViva United Nations Source Type: news

The U.S. Government's Push For Coronavirus Vaccine 'Warp Speed' Faces Potential Black Hole Of Red Tape And Universe Of Unknowns
Dr. Stephen Thomas, who helped develop vaccine candidates for diseases such as Ebola, Zika and MERS, discusses the challenges involved in accelerating development during a pandemic. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 16, 2020 Category: Pharmaceuticals Authors: Stephen Thomas, Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science Business /business Policy /policy Editors' Pick editors-pick Decision Maker decision-maker Coronavirus Source Type: news

New Report: 1,200+ Incidents of Violence Against Health Care in 2019
This article was originally published by theSafeguarding Health in Conflict Coalition. (Source: IntraHealth International)
Source: IntraHealth International - June 11, 2020 Category: International Medicine & Public Health Authors: cbishopp Tags: Safeguarding Health in Conflict Coalition Global health security Health Workers Source Type: news

What is lost in the smoke of COVID-19
Devyn Holliday, Research Officer, Economic, Youth & Sustainable Development Directorate   This blog is part of the seminar series on ‘The Economics of COVID-19’.By Devyn HollidayJun 10 2020 (IPS-Partners) When countries shuttered their shops, closed their markets, and cordoned off places of gathering to help ward off the coronavirus, they did so out of immediate concern for the health and wellbeing of their citizens. However, as these measures endure the virus is no longer the sole threat to the health and wellbeing of citizens. People across the globe are facing mounting threats to their wellbeing ...
Source: IPS Inter Press Service - Health - June 10, 2020 Category: International Medicine & Public Health Authors: Devyn Holliday Tags: Economy & Trade Health Labour Source Type: news

Melinda Gates Lays Out Her Biggest Concern For the Next Phase of the COVID-19 Pandemic
From 2018-2019, the Bill and Melinda Gates Foundation gave more money to the World Health Organization than any entity except the U.S. government. With President Donald Trump cutting ties to the international health agency in the midst of the COVID-19 pandemic, the Gates Foundation’s work has come into sharper relief than ever. Co-chair Bill Gates announced at the Global Vaccine Summit on June 4 that it will give $1.6 billion over five years to the Vaccine Alliance (GAVI), to help ensure that people around the world have access to vaccines, regardless of income. The Gates Foundation in 1999 pledged $750 million to he...
Source: TIME: Health - June 4, 2020 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 Source Type: news